More importantly, our findings reveal that MMC reduces the recurrence rate of pterygium by suppressing angiogenesis and fibroblast proliferation via inhibiting NLRP3/Caspase-1 pathway activation and the expression of inflammatory factors such as TGF-β1, VEGF, IL-6. Here, TGFB1 is linked to pterygium.